| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/18/2010 | US20100040643 Flavivirus immunogens and methods of use |
| 02/18/2010 | US20100040641 Peptide vaccines for cancers expressing tumor-associated antigens |
| 02/18/2010 | US20100040640 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide |
| 02/18/2010 | US20100040638 Smoking cessation kit and method |
| 02/18/2010 | US20100040637 Methods and Composition for Treating Diseases Targeting Prominin-1 (CD133) |
| 02/18/2010 | US20100040634 Methods and compositions for modulating hgf/met |
| 02/18/2010 | US20100040629 Antibodies to c-Met |
| 02/18/2010 | US20100040624 Human Tumor Necrosis Factor TR21 and Methods Based Thereon |
| 02/18/2010 | US20100040621 Novel polpeptide and use thereof |
| 02/18/2010 | US20100040615 Digalactolipidic Antigen Exposed on the Surface of Apicomplex Parasites, and Diagnostic and Therapeutic Use Thereof |
| 02/18/2010 | US20100040613 Polypeptide constructs for sublingual administration |
| 02/18/2010 | US20100040610 Antagonists of pcsk9 |
| 02/18/2010 | US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 02/18/2010 | US20100040553 Spherical ferrite nanoparticle and method for production thereof |
| 02/18/2010 | US20100040552 Methods to evaluate glucocorticoid receptor agonists and antagonists for effects on neuron-like cells |
| 02/18/2010 | US20100040539 Vector System |
| 02/18/2010 | US20100039124 Molecularly Imprinted Polymer Sensor Systems And Related Methods |
| 02/18/2010 | US20100038997 Coating for harsh environments and sensors using same |
| 02/18/2010 | US20100038262 Detection of Analytes Using Reorganization Energy |
| 02/18/2010 | US20100037713 Pharmaceutical Analysis Apparatus and Method |
| 02/18/2010 | DE102009013069A1 Verfahren und Vorrichtung zur Beschaffenheitsuntersuchung von säulenförmigen oder zylindrischen Abschnitten von Körpern Method and device for quality testing of columnar or cylindrical sections of bodies |
| 02/18/2010 | DE102008038902A1 Behälter Container |
| 02/18/2010 | CA2737556A1 Porous materials for biological sample collection |
| 02/18/2010 | CA2735578A1 Method of identifying disease risk factors |
| 02/18/2010 | CA2734389A1 S0x9, prostaglandin d2 and retinoic acid for treating pigmentary conditions and melanoma |
| 02/18/2010 | CA2734379A1 Ragweed peptides for vaccine |
| 02/18/2010 | CA2734322A1 Na channels, disease, and related assays and compositions |
| 02/18/2010 | CA2734321A1 Flow cytometry-based systems and methods for detecting microbes |
| 02/18/2010 | CA2734244A1 Detecting nucleic acid |
| 02/18/2010 | CA2734179A1 Micro-rna-based compositions and methods for the diagnosis, prognosis and treatment of multiple myeloma |
| 02/18/2010 | CA2733994A1 Fluorescent emulsion |
| 02/18/2010 | CA2733990A1 Biomarker detection process and assay of neurological condition |
| 02/18/2010 | CA2733964A1 Wnt1 as a renal damage biomarker |
| 02/18/2010 | CA2733905A1 Compositions and methods for influencing satiety, lipid metabolism, and fat utilization |
| 02/18/2010 | CA2733763A1 Methods for measurement of fluid electrical stability |
| 02/18/2010 | CA2733670A1 Methods for identifying compounds which inhibit binding of anthrax protein to lrp5/6 receptors |
| 02/18/2010 | CA2733597A1 Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity |
| 02/18/2010 | CA2733545A1 Modified biotin-binding protein |
| 02/18/2010 | CA2733361A1 Blood-platelet test method and blood-platelet test device |
| 02/18/2010 | CA2732823A1 Ex vivo therapeutic screening of living bone marrow cells for multiple myeloma |
| 02/18/2010 | CA2732201A1 D-dimer, troponin, nt-probnp for pulmonary embolism |
| 02/18/2010 | CA2676178A1 A method of diagnosing a respiratory disease |
| 02/17/2010 | EP2154705A1 Method for measuring adsorbed and interstitial fluids |
| 02/17/2010 | EP2154536A1 Detection method and detection reagent for autoimmune pancreatitis or fulminant type-1 diabetes |
| 02/17/2010 | EP2154535A1 Protein scaffolds for antibody mimics and other binding proteins |
| 02/17/2010 | EP2154534A1 Multichemistry measuring device and test strips |
| 02/17/2010 | EP2154533A1 Method for determining SUMOylation |
| 02/17/2010 | EP2154532A2 Analyte testing method and system |
| 02/17/2010 | EP2154531A1 Method for analysis of metal sample |
| 02/17/2010 | EP2154530A2 Method and apparatus for detection, measurement and control of sulfur-trioxide and other condensables in flue gas |
| 02/17/2010 | EP2154529A2 Method for evaluating gas sensor signals |
| 02/17/2010 | EP2154522A2 Biosensor |
| 02/17/2010 | EP2154511A2 Apparatus and method for measuring the coagulation characteristics of a test liquid |
| 02/17/2010 | EP2154267A2 Apparatus for in-line testing of a chemical in a water containing system |
| 02/17/2010 | EP2154248A1 Compounds and methods for diagnosis of tuberculosis |
| 02/17/2010 | EP2154245A2 Composition and method for diagnosing kidney cancer and for predicting prognosis for kidney cancer patient |
| 02/17/2010 | EP2154156A2 Analysis of agonist-activity and antagonist-activity to cytokinin receptor |
| 02/17/2010 | EP2154155A2 Analysis of agonist-activity and antagonist-activity to cytokinin receptor |
| 02/17/2010 | EP2154154A1 G-protein-conjugated receptor having altered ligand affinity, and use thereof |
| 02/17/2010 | EP2153848A2 Therapeutic monoclonal antibodies that neutralize botulinium neurotoxins |
| 02/17/2010 | EP2153847A1 Gene sensitive to bone/joint disease and use thereof |
| 02/17/2010 | EP2153843A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/17/2010 | EP2153840A1 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin |
| 02/17/2010 | EP2153829A1 Methods of preventing, treating and diagnosing disorders of protein aggregation |
| 02/17/2010 | EP2153775A1 Analysis instrument |
| 02/17/2010 | EP2153411A1 Automatic characterization of cellular motion |
| 02/17/2010 | EP2153236A1 Method for assessing the risk of a cardiovascular disease and for diagnosing dyslipidemia |
| 02/17/2010 | EP2153235A1 Methods of measuring inhibition of platelet aggregation by thrombin receptor antagonists |
| 02/17/2010 | EP2153234A2 Methods for early diagnosis of kidney disease |
| 02/17/2010 | EP2153233A1 Method for predicting the outcome of a critically ill patient |
| 02/17/2010 | EP2153232A1 Serum biomarkers for the early detection of lung cancer |
| 02/17/2010 | EP2153231A2 Malt1 specific cleavage in assay and screening method |
| 02/17/2010 | EP2153230A1 Assay for detecting mycobacterial infection |
| 02/17/2010 | EP2153229A1 Use of auto-antibodies against cd28 as a prognostic marker in malignant melanoma |
| 02/17/2010 | EP2153228A1 Methods for detecting cardiac damage |
| 02/17/2010 | EP2153227A2 Reagents and methods for the determination of pk/adme-tox characteristics of new chemical entities and of drug candidates |
| 02/17/2010 | EP2153226A2 Means and methods for classifying samples of multiple sclerosis patients |
| 02/17/2010 | EP2153225A1 Diagnostic device and method for testing hydration and other conditions |
| 02/17/2010 | EP2153224A2 Subsystems and methods for use in patch clamp systems |
| 02/17/2010 | EP2153223A2 Computational diagnostic methods for identifying organisms and applications thereof |
| 02/17/2010 | EP2153222A1 Method and device for measuring the composition of fibrous suspensions |
| 02/17/2010 | EP2153221A1 Measuring air quality using a micro-optical mechanical gas sensor |
| 02/17/2010 | EP2153220A2 Continuous monitor for cyanide and cyanogen blood agent detection in water |
| 02/17/2010 | EP2153217A1 Method for determining the sensitive or insensitive nature of a hexogen |
| 02/17/2010 | EP2153214A1 Apparatus for characterizing a surface structure |
| 02/17/2010 | EP2153206A1 Method and apparatus for preparing cheese from milk |
| 02/17/2010 | EP2153203A1 Method for employing a biosensor to detect small molecules that bind directly to immobilized targets |
| 02/17/2010 | EP2153199A2 Systems and methods for focusing particles |
| 02/17/2010 | EP2152913A2 Detection device for detecting biological microparticles such as bacteria, viruses, spores, pollen or biological toxins, and detection method |
| 02/17/2010 | EP2152912A1 In situ methods for gene mapping and haplotyping |
| 02/17/2010 | EP2152905A2 Methods and kits for detecting fetal cells in the maternal blood |
| 02/17/2010 | EP2152882A2 Cells expressing chimeric proteins and assays using such cells |
| 02/17/2010 | EP2152859A2 Method and device for non- invasive prenatal diagnosis |
| 02/17/2010 | EP2152744A1 Prion protein as a receptor for amyloid-beta oligomers |
| 02/17/2010 | EP2152727A1 Peptide standards |
| 02/17/2010 | EP2152629A1 Forming crosslinked-glutathione on nanostructure |
| 02/17/2010 | EP2152418A2 Detecting isomers using differential derivatization mass spectrometry |
| 02/17/2010 | EP2152416A1 Analytical devices with intedrated desiccant |
| 02/17/2010 | EP2152276A1 Screening assay to identify correctors of protein trafficking defects |
| 02/17/2010 | EP2049008B1 Packaging containing a microfluidic element having a hydrophilic surface coating |